TrialEuropean heart journal2025

Efficacy of aficamten in patients with obstructive hypertrophic cardiomyopathy and mild symptoms: results from the SEQUOIA-HCM trial.

Martin S Maron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.